Large peptide capacity JPT offers a high-volume peptide synthesis capability (over 1 million peptides per year) with a wide range of modifications, presenting a strong opportunity to upsell large-scale, customized peptide projects and long-term collaborations.

Clinical and immune focus Their PepMix pools and clinical-grade peptides support immune monitoring, vaccine development, immunotherapy, and cell therapy workflows, suggesting a fit for customers in translational research, oncology, infectious disease, and clinical proteomics.

Global expertise With Made in Germany manufacturing, two decades of experience, and global support, JPT can reassure international buyers about quality, regulatory alignment, and reliable supply chains for multinational collaborations and CRO partnerships.

Diversified product set Offering modified peptides, macrocyclic and labeled peptides, radioligands, and isotope labeling enables cross-selling to customers needing complex peptide constructs, assay controls, and specialized research reagents.

Proven tooling readiness History of launching ready-to-use peptide tools and extensive PepMix inventories indicates readiness to accelerate customer programs, enabling faster time-to-result for immune profiling, assay development, and vaccine research.